Daruwala Paul
Insider CIK 1639144 · CDTX Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CDTX Cidara Therapeutics, Inc. | S Sale | 2022-09-12 | 2022-09-13 | 16,199 | $0.68 | $11.0K | 221,099 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2022-03-31 | 2022-04-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award | 2022-03-31 | 2022-04-04 | 50,000 | — | $0 | 237,298 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | S Sale | 2022-01-05 | 2022-01-07 | 5,133 | $1.25 | $6.4K | 187,298 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | M Exercise deriv | 2021-12-29 | 2022-01-07 | 4,900 | — | $0 | 5,600 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | M Exercise deriv | 2021-12-29 | 2022-01-07 | 5,000 | — | $0 | 12,500 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | M Exercise | 2021-12-29 | 2022-01-07 | 9,900 | — | $0 | 192,431 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award | 2021-09-30 | 2021-10-04 | 132,000 | — | $0 | 182,531 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | S Sale | 2021-04-01 | 2021-04-05 | 593 | $2.66 | $1.6K | 50,531 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award | 2021-03-31 | 2021-04-05 | 1,400 | — | $0 | 51,124 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2021-03-17 | 2021-03-19 | 120,000 | — | $0 | 120,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | S Sale | 2021-01-05 | 2021-04-05 | 2,868 | $2.06 | $5.9K | 49,724 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2020-03-19 | 2020-03-23 | 90,000 | — | $0 | 90,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | S Sale | 2020-01-03 | 2020-06-25 | 940 | $3.42 | $3.2K | 52,592 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | S Sale | 2020-01-03 | 2020-01-06 | 2,340 | $3.42 | $8.0K | 53,532 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2019-12-18 | 2019-12-20 | 33,333 | — | $0 | 33,333 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2019-12-18 | 2019-12-20 | 50,000 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2019-12-18 | 2019-12-20 | 4,074 | — | $0 | 4,074 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2019-12-18 | 2019-12-20 | 25,688 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2019-12-18 | 2019-12-20 | 55,000 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2019-12-18 | 2019-12-20 | 32,592 | — | $0 | 32,592 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2019-12-18 | 2019-12-20 | 17,125 | — | $0 | 17,125 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | S Sale | 2019-10-02 | 2019-10-03 | 3,295 | $1.88 | $6.2K | 55,872 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | M Exercise deriv | 2019-09-12 | 2019-09-16 | 7,500 | — | $0 | 17,500 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | M Exercise deriv | 2019-09-12 | 2019-09-16 | 2,100 | — | $0 | 11,900 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award | 2019-09-12 | 2019-09-16 | 7,500 | — | $0 | 57,067 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award | 2019-09-12 | 2019-09-16 | 2,100 | — | $0 | 59,167 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2019-03-21 | 2019-03-22 | 77,000 | — | $0 | 77,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | S Sale | 2019-03-07 | 2019-03-08 | 2,240 | $2.55 | $5.7K | 49,567 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | M Exercise deriv | 2019-01-31 | 2019-02-01 | 14,000 | — | $0 | 14,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award | 2019-01-31 | 2019-02-01 | 6,000 | — | $0 | 51,807 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2018-03-29 | 2018-04-02 | 72,000 | — | $0 | 72,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | M Exercise deriv | 2017-09-18 | 2017-09-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award | 2017-09-18 | 2017-09-19 | 15,000 | — | $0 | 45,807 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2017-03-31 | 2017-04-04 | 55,000 | — | $0 | 55,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2016-03-16 | 2016-03-18 | 50,000 | — | $0 | 50,000 | SEC↗ |